Searched for
MSD REVIEW
Stocks in news: Rajesh Exports, Lenskart, Suzlon Energy, Aurobindo Pharma, Tata MotorsIndian markets saw volatility and closed lower on Wednesday. Key companies are in focus due to significant developments. SoftBank reduced i...- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- India, US to launch emerging defence capabilities dialogue soonThe Indian delegation for the inter-sessional meeting on Wednesday was led by Vani Rao, Additional Secretary (Americas) in the Ministry of ...
- Molnupiravir reduced Covid-linked hospitalisation by over 65%: StudyThe Phase III trial results of Hetero's Movfor (Molnupiravir), presented at the Conference on Retroviruses and Opportunistic Infections (CR...
- Torrent Pharma to launch Molnupiravir under Molnutor brand name to treat COVID-19Torrent Pharmaceuticals on Tuesday said it will launch MSD and Ridgeback's molnupiravir under the brand name Molnutor in India for the trea...
- Govt panel weighing risks and benefits of Merck's Covid drugThe Subject Expert Committee (SEC) under the drug regulator of India has asked manufacturers in India to specify the category of Covid pati...
- USFDA approves COVID antiviral pill molnupiravir for emergency useThe USFDA also said the drug should be given for whom alternative COVID-19 treatment options authorized by the FDA are not accessible or cl...
- Panel seeks extra data on Merck's Covid drugThe SEC of the Central Drugs Standard Control Organisation (CDSCO) on Monday reviewed applications from Dr Reddy's, Hetero Labs, Natco Phar...
- COVID antiviral drug Molnupiravir efficacy against hospitalization or death drops to 30% compared to placebo groupThe analysis of latest data on efficacy is much less than the previous interim analysis announced by the company which was based on data fr...
- Expert panel seeks additional info on Merck's Covid-19 drugMolnupiravir is the first oral antiviral approved by the UK Medicines and Healthcare products Regulatory Agency (MHRA) for the treatment of...
- Sun Pharma says gearing up to launch COVID drug molnupiravirThe company said the Drugs Controller General of India (DCGI) is currently reviewing clinical data of molnupiravir for the treatment of COV...
- With UK nod, Merck drug becomes world's 1st pill for Covid treatmentThe MHRA recommended the use of Covid-19 drug molnupiravir as soon as possible following a positive Covid-19 test and within five days of s...
- UK drug regulatory approves COVID antiviral drug MolnupiravirThe risk factors include obesity, older age (>60 years), diabetes mellitus, or heart disease. MHRA recommended the use of Molnupiravir as s...
- Centre likely to cap veterinary drug pricesCentre is mulling to cap the prices of a new catalogue of veterinary drugs and vaccines in a bid to boost the Prime Minister's new initiati...
- Sun Pharmaceutical signs agreement with Samsung BioLogics for psoriasis drugThe novel drug known as Tildrakizumab is currently under review by the US FDA and the European Medicines Agency (EMA). The value of the con...
- 'MS Dhoni: The Untold Story' review: A one-man show, thanks to Sushant Singh RajputFor Dhoni fans, 'MS Dhoni-The Untold Story,' is a must-watch! For Neeraj Pandey's followers, this is watchable but not his best!
- ET Review: Maxx MSD7 3G AX46The 1,300mAh battery struggled to last one full day. In fact with 3G constant on, we had to recharge the device twice in a day.
- SMS, RTI potent tools of drug companies fighting patent battleInnovator drugmakers have started gleaning information from messages sent out by rival cos and websites of drug distributors to take a peek...
- 'We will continue to sell our patented drugs with India-specific pricing'KG Ananthakrishnan, MD, MSD India spoke on future strategy and shared his views on Indian govt's proposals on contentious issues such as co...
- Merck secures 2 patents in India, to pursue moreUS-based Merck has received patent approval from the Indian Patent Office for two of its upcoming drugs for dyslipidemia and obesity.
Load More
